Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

1 min read
Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

Generic drugmaker Hetero has received Drug Controller General of India approval to manufacture and sell its generic version of Gilead’s Ramdesivir for the treatment of COVID-19 patients. The generic version will be marked under the brand name ‘Covifor’ in India. Covifor will be available in 100-milligram vial ( injectable)  which has to be administrated intravenously in a hospital setting under the supervision of a health care practitioner. The product is being manufactured at its facility in Hyderabad. 

DCGI has granted approval for the use of Remidviser in the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children, hospitalised with severe symptoms of the disease. Covifor will be available in 100-milligram vial ( injectable)  which has to be administrated intravenously in a hospital setting under the supervision of a health care practitioner.   

https://youtu.be/Np5W8dqk1do

 Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

 

read more:

Glenmark launches COVID-19 drug after DCGI nod 
Glenmark launches COVID-19 drug after DCGI nod
First steel bridge in Hyderabad inaugurated
First steel bridge in Hyderabad inaugurated

No more lockdowns, only unlocking
No more lockdowns, only unlocking
Coronavirus cases in Telangana – 21-06-2020 – charan news
Coronavirus cases in Telangana – 21-06-2020 – charan news
Coronavirus treatment drug: Hetero launches drug for COVID-19 patients
Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

Leave a Reply

Your email address will not be published. Required fields are marked *